High tumor incidence and activation of the PI3K/AKT pathway in transgenic mice define AIB1 as an oncogene

Cancer Cell

Volumn 6, Issue 3, 2004, Pages 263-274

  Torres Arzayus, Maria I ^a   De Mora, Jaime Font ^a   Yuan, Jing ^a   Vazquez, Francisca ^a   Bronson, Roderick ^b   Rue, Montserrat ^a   Sellers, William R ^a   Brown, Myles ^a  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; AUTOCRINE EFFECT; BREAST CANCER; BREAST EPITHELIUM; BREAST HYPERPLASIA; BREAST HYPERTROPHY; CANCER INCIDENCE; CELL ACTIVATION; CELL CULTURE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE OVEREXPRESSION; GENETIC CODE; HYPOPHYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSGENIC MOUSE; TUMOR LOCALIZATION; UTERUS; WEANING;

ANIMALIA; MUS MUSCULUS;

EID: 4544314561     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2004.06.027     Document Type: Article

References (56)

1. Anzick S.L., Kononen J., Walker R.L., Azorsa D.O., Tanner M.M., Guan X.Y., Sauter G., Kallioniemi O.P., Trent J.M., Meltzer P.S. AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer. Science. 277:1997;965-968
2. Bai J., Uehara Y., Montell D.J. Regulation of invasive cell behavior by taiman, a Drosophila protein related to AIB1, a steroid receptor coactivator amplified in breast cancer. Cell. 103:2000;1047-1058
3. Bautista S., Valles H., Walker R.L., Anzick S., Zeillinger R., Meltzer P., Theillet C. In breast cancer, amplification of the steroid receptor coactivator gene AIB1 is correlated with estrogen and progesterone receptor positivity. Clin. Cancer Res. 4:1998;2925-2929
4. Bouras T., Southey M.C., Venter D.J. Overexpression of the steroid receptor coactivator AIB1 in breast cancer correlates with the absence of estrogen and progesterone receptors and positivity for p53 and HER2/neu. Cancer Res. 61:2001;903-907
5. Cardiff R.D., Muller W.J. Transgenic mouse models of mammary tumorigenesis. Cancer Surv. 16:1993;97-113
6. Cardiff R.D., Anver M.R., Gusterson B.A., Hennighausen L., Jensen R.A., Merino M.J., Rehm S., Russo J., Tavassoli F.A., Wakefield L.M., et al. The mammary pathology of genetically engineered mice. The consensus report and recommendations from the Annapolis meeting Oncogene. 19:2000;968-988
7. Chen H., Lin R.J., Schiltz R.L., Chakravarti D., Nash A., Nagy L., Privalsky M.L., Nakatani Y., Evans R.M. Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300. Cell. 90:1997;569-580
8. Choi Y.W., Henrard D., Lee I., Ross S.R. The mouse mammary tumor virus long terminal repeat directs expression in epithelial and lymphoid cells of different tissues in tg mice. J. Virol. 61:1987;3013-3019
9. Conlon I., Raff M. Size control in animal development. Cell. 96:1999;235-244
10. Cui X., Lazard Z., Zhang P., Hopp T.A., Lee A.V. Progesterone crosstalks with insulin-like growth factor signaling in breast cancer cells via induction of insulin receptor substrate-2. Oncogene. 22:2003;6937-6941. a
11. Cui X., Zhang P., Deng W., Oesterreich S., Lu Y., Mills G.B., Lee A.V. Insulin-like growth factor-I inhibits progesterone receptor expression in breast cancer cells via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin pathway. Progesterone receptor as a potential indicator of growth factor activity in breast cancer Mol. Endocrinol. 17:2003;575-588. b
12. Dupont J., Karas M., LeRoith D. The potentiation of estrogen on insulin-like growth factor I action in MCF-7 human breast cancer cells includes cell cycle components. J. Biol. Chem. 275:2000;35893-35901
13. Fedele M., Battista S., Kenyon L., Baldassarre G., Fidanza V., Klein-Szanto A.J., Parlow A.F., Visone R., Pierantoni G.M., Outwater E., et al. Overexpression of the HMGA2 gene in tg mice leads to the onset of pituitary adenomas. Oncogene. 21:2002;3190-3198
14. Font de Mora J., Brown M. AIB1 is a conduit for kinase-mediated growth factor signaling to the estrogen receptor. Mol. Cell. Biol. 20:2000;5041-5047
15. Gingras A.C., Raught B., Sonenberg N. Regulation of translation initiation by FRAP/mTOR. Genes Dev. 15:2001;807-826
16. Glass C.K., Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 14:2000;121-141
17. Gunzburg W.H., Salmons B. Factors controlling the expression of mouse mammary tumour virus. Biochem. J. 283:1992;625-632
18. Hadsell D.L., Abdel-Fattah G. Regulation of cell apoptosis by insulin-like growth factor I. Adv. Exp. Med. Biol. 501:2001;79-85
19. Halachmi S., Marden E., Martin G., MacKay H., Abbondanza C., Brown M. Estrogen receptor-associated proteins. possible mediators of hormone-induced transcription Science. 264:1994;1455-1458
20. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell. 100:2000;57-70
21. Kaplan E., Meier P. Non-parametric estimation for incomplete observation. J. Am. Stat. Assoc. 53:1958;457-471
22. King L.B., Corley R.B. Lipopolysaccharide and dexamethasone induce mouse mammary tumor proviral gene expression and differentiation in B lymphocytes through distinct regulatory pathways. Mol. Cell. Biol. 10:1990;4211-4220
23. Leevers S.J., Weinkove D., MacDougall L.K., Hafen E., Waterfield M.D. The Drosophila phosphoinositide 3-kinase Dp110 promotes cell growth. EMBO J. 15:1996;6584-6594
24. LeRoith D., Roberts C.T. Jr. The insulin-like growth factor system and cancer. Cancer Lett. 195:2003;127-137
25. Li G., Robinson G.W., Lesche R., Martinez-Diaz H., Jiang Z., Rozengurt N., Wagner K.U., Wu D.C., Lane T.F., Liu X., et al. Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland. Development. 129:2002;4159-4170
26. Liao L., Kuang S.Q., Yuan Y., Gonzalez S.M., O'Malley B.W., Xu J. Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3/AIB1. J. Steroid Biochem. Mol. Biol. 83:2002;3-14
27. List H.J., Reiter R., Singh B., Wellstein A., Riegel A.T. Expression of the nuclear coactivator AIB1 in normal and malignant breast tissue. Breast Cancer Res. Treat. 68:2001;21-28
28. McKenna N.J., Xu J., Nawaz Z., Tsai S.Y., Tsai M.J., O'Malley B.W. Nuclear receptor coactivators. Multiple enzymes, multiple complexes, multiple functions J. Steroid Biochem. Mol. Biol. 69:1999;3-12
29. Medina D., Kittrell F. Establishment of mouse mammary cell lines. Ip M.M., Asch B.B. Methods in Mammary Gland Biology and Breast Cancer Research. 2000;137-145 Kluwer Academic/Plenum publishers, Buffalo, NY
30. Mills G.B., Lu Y., Fang X., Wang H., Eder A., Mao M., Swaby R., Cheng K.W., Stokoe D., Siminovitch K., et al. The role of genetic abnormalities of PTEN and the phosphatidylinositol 3-kinase pathway in breast and ovarian tumorigenesis, prognosis, and therapy. Semin. Oncol. 28:2001;125-141
31. Miyoshi K., Shillingford J.M., Le Provost F., Gounari F., Bronson R., von Boehmer H., Taketo M.M., Cardiff R.D., Hennighausen L., Khazaie K. Activation of β-catenin signaling in differentiated mammary secretory cells induces transdifferentiation into epidermis and squamous metaplasias. Proc. Natl. Acad. Sci. USA. 99:2002;219-224
32. Muller W.J., Sinn E., Pattengale P.K., Wallace R., Leder P. Single-step induction of mammary adenocarcinoma in tg mice bearing the activated c-neu oncogene. Cell. 54:1988;105-115
33. Muller W.J., Lee F.S., Dickson C., Peters G., Pattengale P., Leder P. The int-2 gene product acts as an epithelial growth factor in tg mice. EMBO J. 9:1990;907-913
34. Munoz B., Bolander F.F. Jr. Prolactin regulation of mouse mammary tumor virus (MMTV) expression in normal mouse mammary epithelium. Mol. Cell. Endocrinol. 62:1989;23-29
35. Osborne C.K., Bardou V., Hopp T.A., Chamness G.C., Hilsenbeck S.G., Fuqua S.A., Wong J., Allred D.C., Clark G.M., Schiff R. Role of the estrogen receptor coactivator AIB1 (SRC-3) and HER-2/neu in tamoxifen resistance in breast cancer. J. Natl. Cancer Inst. 95:2003;353-361
36. Patel S., Lochhead P.A., Rena G., Fumagalli S., Pende M., Kozma S.C., Thomas G., Sutherland C. Insulin regulation of insulin-like growth factor-binding protein-1 gene expression is dependent on the mammalian target of rapamycin, but independent of ribosomal S6 kinase activity. J. Biol. Chem. 277:2002;9889-9895
37. Peto R., Peto J. Asymptotically efficient rank invariant test procedures (with discussion). J. R. Stat. Soc. A. 135:1972;185-207
38. Reginato M.J., Mills K.R., Paulus J.K., Lynch D.K., Sgroi D.C., Debnath J., Muthuswamy S.K., Brugge J.S. Integrins and EGFR coordinately regulate the pro-apoptotic protein Bim to prevent anoikis. Nat. Cell Biol. 5:2003;733-740
39. Sakakura C., Hagiwara A., Yasuoka R., Fujita Y., Nakanishi M., Masuda K., Kimura A., Nakamura Y., Inazawa J., Abe T., Yamagishi H. Amplification and over-expression of the AIB1 nuclear receptor co-activator gene in primary gastric cancers. Int. J. Cancer. 89:2000;217-223
40. Scheid M.P., Woodgett J.R. Phosphatidylinositol 3′ kinase signaling in mammary tumorigenesis. J. Mammary Gland Biol. Neoplasia. 6:2001;83-99
41. Scheinman R.I., Cogswell P.C., Lofquist A.K., Baldwin A.S. Jr. Role of transcriptional activation of IκBα in mediation of immunosuppression by glucocorticoids. Science. 270:1995;283-286
42. Shang Y., Hu X., DiRenzo J., Lazar M.A., Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell. 103:2000;843-852
43. Suen C.S., Berrodin T.J., Mastroeni R., Cheskis B.J., Lyttle C.R., Frail D.E. A transcriptional coactivator, steroid receptor coactivator-3, selectively augments steroid receptor transcriptional activity. J. Biol. Chem. 273:1998;27645-27653
44. Surmacz E. Growth factor receptors as therapeutic targets. Strategies to inhibit the insulin-like growth factor I receptor Oncogene. 22:2003;6589-6597
45. Takeshita A., Cardona G.R., Koibuchi N., Suen C.S., Chin W.W. TRAM-1, A novel 160-kDa thyroid hormone receptor activator molecule, exhibits distinct properties from steroid receptor coactivator-1. J. Biol. Chem. 272:1997;27629-27634
46. Torchia J., Rose D.W., Inostroza J., Kamei Y., Westin S., Glass C.K., Rosenfeld M.G. The transcriptional co-activator p/CIP binds CBP and mediates nuclear-receptor function. Nature. 387:1997;677-684
47. Umayahara Y., Kawamori R., Watada H., Imano E., Iwama N., Morishima T., Yamasaki Y., Kajimoto Y., Kamada T. Estrogen regulation of the insulin-like growth factor I gene transcription involves an AP-1 enhancer. J. Biol. Chem. 269:1994;16433-16442
48. Vivanco I., Sawyers C.L. The phosphatidylinositol 3-kinase AKT pathway in human cancer. Nat. Rev. Cancer. 2:2002;489-501
49. Wakefield L.M., Thordarson G., Nieto A.I., Shyamala G., Galvez J.J., Anver M.R., Cardiff R.D. Spontaneous pituitary abnormalities and mammary hyperplasia in FVB/NCr mice. implications for mouse modeling Comp. Med. 53:2003;424-432
50. Wang T.C., Cardiff R.D., Zukerberg L., Lees E., Arnold A., Schmidt E.V. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature. 369:1994;669-671
51. Wang Z., Rose D.W., Hermanson O., Liu F., Herman T., Wu W., Szeto D., Gleiberman A., Krones A., Pratt K., et al. Regulation of somatic growth by the p160 coactivator p/CIP. Proc. Natl. Acad. Sci. USA. 97:2000;13549-13554
52. Wang Y., Wu M.C., Sham J.S., Zhang W., Wu W.Q., Guan X.Y. Prognostic significance of c-myc and AIB1 amplification in hepatocellular carcinoma. A broad survey using high-throughput tissue microarray. Cancer. 95:2002;2346-2352
53. Werbajh S., Nojek I., Lanz R., Costas M.A. RAC-3 is a NF-κB coactivator. FEBS Lett. 485:2000;195-199
54. Wu R.C., Qin J., Hashimoto Y., Wong J., Xu J., Tsai S.Y., Tsai M.J., O'Malley B.W. Regulation of SRC-3 (pCIP/ACTR/AIB-1/RAC-3/TRAM-1) Coactivator activity by IκB kinase. Mol. Cell. Biol. 22:2002;3549-3561
55. Xu J., Qiu Y., DeMayo F.J., Tsai S.Y., Tsai M.J., O'Malley B.W. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene. Science. 279:1998;1922-1925
56. Xu J., Liao L., Ning G., Yoshida-Komiya H., Deng C., O'Malley B.W. The steroid receptor coactivator SRC-3 (p/CIP/RAC3/AIB1/ACTR/TRAM-1) is required for normal growth, puberty, female reproductive function, and mammary gland development. Proc. Natl. Acad. Sci. USA. 97:2000;6379-6384